Q3 2023 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2023-11-14 · accession 0001420506-23-002084
$722.3M
Reported value
65
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 88033G407 | THC | TENET HEALTHCARE CORP | $35.6M | 4.93% | 540,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $34.4M | 4.76% | 70,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $29.0M | 4.02% | 550,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $28.5M | 3.95% | 500,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $23.6M | 3.26% | 800,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $23.5M | 3.25% | 300,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $22.9M | 3.17% | 350,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $21.7M | 3.01% | 50,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $20.8M | 2.88% | 105,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $20.4M | 2.82% | 200,000 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $19.8M | 2.74% | 110,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $17.5M | 2.42% | 65,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $17.2M | 2.38% | 60,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $16.8M | 2.33% | 65,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $16.8M | 2.32% | 250,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $16.3M | 2.26% | 175,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $14.9M | 2.07% | 430,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $14.5M | 2.01% | 525,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $13.4M | 1.86% | 25,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $12.5M | 1.73% | 275,000 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $11.5M | 1.59% | 35,000 | Common | SOLE |
| 87918A105 | TDOC | TELADOC HEALTH INC | $11.2M | 1.54% | 600,000 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $11.1M | 1.53% | 100,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $11.1M | 1.53% | 525,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $10.9M | 1.51% | 25,000 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $10.3M | 1.43% | 485,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $10.2M | 1.41% | 1,000,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $9.6M | 1.33% | 325,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.6M | 1.32% | 85,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $9.0M | 1.25% | 450,000 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $8.9M | 1.24% | 1,300,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.9M | 1.23% | 800,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $8.8M | 1.23% | 200,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $8.7M | 1.20% | 125,000 | Common | SOLE |
| 61559X954 | — | MOONLAKE IMMUNOTHERAPEUTICS | $8.6M | 1.18% | 150,000 | PUT | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $8.4M | 1.16% | 748,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $8.1M | 1.12% | 70,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $7.9M | 1.09% | 70,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $7.7M | 1.07% | 275,000 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $7.3M | 1.01% | 160,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.3M | 1.00% | 275,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $6.9M | 0.96% | 133,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $6.7M | 0.93% | 800,000 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $6.7M | 0.92% | 800,000 | Common | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS INC | $6.1M | 0.84% | 220,000 | Common | SOLE |
| 803607900 | — | SAREPTA THERAPEUTICS INC | $6.1M | 0.84% | 50,000 | CALL | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $5.9M | 0.82% | 200,000 | Common | SOLE |
| 931427108 | WFC | WALGREENS BOOTS ALLIANCE INC | $5.6M | 0.77% | 250,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $5.3M | 0.73% | 450,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $5.1M | 0.71% | 50,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $5.1M | 0.70% | 100,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $5.0M | 0.70% | 330,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $5.0M | 0.69% | 150,000 | Common | SOLE |
| 216648402 | — | COOPER COS INC | $4.8M | 0.66% | 15,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $4.3M | 0.59% | 250,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $4.2M | 0.58% | 760,000 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $4.2M | 0.58% | 150,000 | Common | SOLE |
| 98978V103 | ZTS | ZOETIS INC | $3.5M | 0.48% | 20,000 | Common | SOLE |
| 282559903 | — | 89BIO INC | $3.1M | 0.43% | 200,000 | CALL | SOLE |
| 98262P101 | WW6 | WW INTL INC | $2.8M | 0.38% | 250,000 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $2.7M | 0.37% | 130,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $2.5M | 0.35% | 50,000 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $2.5M | 0.34% | 10,000 | Common | SOLE |
| 82710M100 | SILKUSD | SILK RD MED INC | $2.2M | 0.31% | 150,000 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $1.1M | 0.16% | 100,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.